Japan · Application Performance Management startup
Nanodex, an R&D venture company, provides the synthesis and application of folate-modified cyclodextrins as artificial cancer antibodies.
Funding reportedLast round: Undisclosed round
Funding, as reported
Add your raise, your deck and your story, and put Nanodex in front of investors. Or tell us what we have wrong.